The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Fetterman Draws a Red Line on What Would Cause Him to Quit the Democratic Party
Retiring GOP Sen. Tillis Vows to Block SAVE America Act Any Way He Can: ‘I Will Use Every Device’
Details of Todd Blanche’s behind-the-scenes meeting with Angel Mom revealed after Capitol Hill testimony
FBI investigating after ICE headquarters in Phoenix riddled with gunfire
Kennedy Center tries to regain upper hand in renovation war: ‘Has institutional support’
Troy Jackson, an anti-corporate Maine Senate hopeful, touts endorsements from lobbyists
Intruder Storms ‘Today’ Show Set and Attacks Host
Trump says Josh Shapiro ‘doesn’t have what it takes’ as he moves to define him before 2028
Alleged Feeding Our Future fraud ringleader transferred from Somalia to face US charges
Insurance companies put on notice for stranding trans patients who want to reverse surgeries
GOP’s $95B defense package survives critical hurdle amid fiscal hawk revolt
Blue Angels flyover ignites social media; Hegseth, Eric Trump respond
FCC Set to Rule Against ‘The View’: Report
Navy Launches Investigation After Low Airshow Flyover Causes Chaos on the Ground
Bessent invokes assassination attempt ‘2 hours after being sworn in’ in dramatic brushback of leftist threat
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Fetterman Draws a Red Line on What Would Cause Him to Quit the Democratic Party
Retiring GOP Sen. Tillis Vows to Block SAVE America Act Any Way He Can: ‘I Will Use Every Device’
Details of Todd Blanche’s behind-the-scenes meeting with Angel Mom revealed after Capitol Hill testimony
FBI investigating after ICE headquarters in Phoenix riddled with gunfire
Kennedy Center tries to regain upper hand in renovation war: ‘Has institutional support’
Troy Jackson, an anti-corporate Maine Senate hopeful, touts endorsements from lobbyists
Intruder Storms ‘Today’ Show Set and Attacks Host
Trump says Josh Shapiro ‘doesn’t have what it takes’ as he moves to define him before 2028
Alleged Feeding Our Future fraud ringleader transferred from Somalia to face US charges
Insurance companies put on notice for stranding trans patients who want to reverse surgeries
GOP’s $95B defense package survives critical hurdle amid fiscal hawk revolt
Blue Angels flyover ignites social media; Hegseth, Eric Trump respond
FCC Set to Rule Against ‘The View’: Report
Navy Launches Investigation After Low Airshow Flyover Causes Chaos on the Ground
Bessent invokes assassination attempt ‘2 hours after being sworn in’ in dramatic brushback of leftist threat
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
